Evidence map›Paper›PMID 31921710›Full record

ArticleFrontiers in cellular and infection microbiology2019

Vishwanatha R A P Reddy, William Mwangi, Yashar Sadigh, Venugopal Nair

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Unmasking a Paradox: Roles of the PD-1/PD-L1 Axis in Alzheimer's Disease-Associated Neuroinflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vishwanatha R A P ReddyViral Oncogenesis Group, The Pirbright Institute, Pirbright, United Kingdom.
William MwangiViral Oncogenesis Group, The Pirbright Institute, Pirbright, United Kingdom.
Yashar SadighViral Oncogenesis Group, The Pirbright Institute, Pirbright, United Kingdom.
Venugopal NairViral Oncogenesis Group, The Pirbright Institute, Pirbright, United Kingdom.
The Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L014262/1Biotechnology and Biological Sciences Research Council BB/P016472/1
6 · The paper itself

Abstract

In the present study, we determined the

Indexed as

AnimalsAntibodies, MonoclonalB7-H1 AntigenCell LineChickensChlorocebus aethiopsCloning, MolecularCOS CellsImmunoglobulin Variable RegionMarek DiseaseProgrammed Cell Death 1 ReceptorProtein BindingProtein Interaction Domains and MotifsProtein Sorting SignalsRecombinant ProteinsAntibodies, MonoclonalB7-H1 AntigenImmunoglobulin Variable RegionProgrammed Cell Death 1 ReceptorProtein Sorting SignalsRecombinant ProteinscancerchPD-1chPD-L1monoclonal antibodiespathways

Identifiers

PMID31921710
PMCPMC6930881
OpenAlexW2995602860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.